Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay
Author:
Affiliation:
1. Division of Hematology,
2. Department of Cardiovascular Diseases, and
3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/133/7/763/1552382/blood875252.pdf
Reference24 articles.
1. Natural history and therapy of AL cardiac amyloidosis;Grogan;Heart Fail Rev,2015
2. A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis;Palladini;Blood,2015
3. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death;Muchtar;Blood,2017
4. Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies;Kastritis;Am J Hematol,2015
5. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system;Grogan;J Am Coll Cardiol,2016
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis;ESC Heart Failure;2024-08-31
2. Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system;American Journal of Hematology;2024-08-29
3. Cancer Therapy–Related Cardiac Dysfunction;JACC: CardioOncology;2024-02
4. Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis;JACC: CardioOncology;2024-02
5. Extensive Bi-Atrial Remodeling on Hypertensive Patient with Permanent Atrial Fibrillation Delayed Diagnosis of Fatal Cardiac Lambda Amyloidosis;World Journal of Cardiovascular Diseases;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3